Chemours Faces Investor Suit Over Alleged Exec Misconduct
Law 360
MARCH 21, 2024
Chemical company the Chemours Co. and four of its current and former executives face claims they hurt investors by manipulating a certain financial metric so the executives might receive greater compensation under the company's incentive plans.
Let's personalize your content